Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [14841]

FDA grants accelerated approval to fam-trastuzumab deruxtecan-nxki for unresectable or metastatic HER2-positive solid tumours

FDA grants accelerated approval to fam-trastuzumab deruxtecan-nxki for unresectable or metastatic HER2-positive...

EAU 2024: Five-year interval is safe for prostate cancer screening, research shows

EAU 2024: Five-year interval is safe for prostate cancer screening, research shows

EAU 2024: Urine test halves painful procedures in bladder cancer follow up

EAU 2024: Urine test halves painful procedures in bladder cancer follow up

EAU 2024:Bladder cancer treatment can be better targeted and more effective, trials show

EAU 2024:Bladder cancer treatment can be better targeted and more effective, trials show

New study targets major risk factor for gastric cancer

New study targets major risk factor for gastric cancer

Prolonged use of certain hormone drugs linked to increased brain tumour risk

Prolonged use of certain hormone drugs linked to increased brain tumour risk

Combining epigenetic cancer medications may have benefit for colorectal cancers and other tumour types

Combining epigenetic cancer medications may have benefit for colorectal cancers and other tumour types

New data offer reality check on blood-based colorectal cancer screening

New data offer reality check on blood-based colorectal cancer screening

Epstein-Barr virus hijacks host genome boosting nasopharyngeal carcinoma

Epstein-Barr virus hijacks host genome boosting nasopharyngeal carcinoma

Researchers open a phase 2 clinical trial to test a new combination treatment for glioblastomas

Researchers open a phase 2 clinical trial to test a new combination treatment for glioblastomas

More from ecancer